Concepedia

Heidi J. Peltier

HJ

Statistics

Publications

9

Citations

2.8K

H-Index

9

Active since

2008

Affiliations

Mirna Therapeutics (United States)(Current)

The University of Texas MD Anderson Cancer Center

Woodward (United States)

Asuragen (United States)

Heidi J. Peltier is an author at Mirna Therapeutics (United States) specializing in molecular oncology, oncology, and medicine.

Publications per year

2008–2020

9

Publications

9

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 912 citations · Full text

Medicine, Oncology, Pharmacology +13

Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues

Heidi J. Peltier, Gary J. Latham · RNA · 2008 · 811 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

PDL1 Regulation by p53 via miR-34

María Angélica Cortez, Cristina Ivan, David R. Valdecanas et al. · JNCI Journal of the National Cancer Institute · 2015 · 677 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer

María Angélica Cortez, David R. Valdecanas, Xiaochun Zhang et al. · Molecular Therapy · 2014 · 193 citations · Full text

Medicine, Cancer Biology, Oncology +17

In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation

María Angélica Cortez, David R. Valdecanas, Sharareh Niknam et al. · Molecular Therapy — Nucleic Acids · 2015 · 72 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 9